Growth capital
SCPE commits $50m to India's IFMR, LeapFrog to part exit
Standard Chartered Private Equity (SCPE) has committed $50 million to Indian non-banking finance company (NBFC) IFMR Capital, providing an exit for LeapFrog Investments.
China VC-backed education platform raises extended Series C
Changingedu, a China-based after-school tutoring platform backed by several VC investors, has raised an additional $18 million in an extended Series C round from US-listed Chinese company TAL Education Group.
Hony’s F&B platform leads $11.5m round for China fast food chain
Hony Capital has led a $11.5 million Series B round for Xi Shao Ye, a Chinese fast food chain, through its Hong Kong-listed food and beverage platform Best Food Holding.
Denham-backed platform acquires Australian renewables projects
Resources-focused private equity firm Denham Capital has invested in three renewable energy projects across Australia via its Singapore-based investment platform Nexif Energy.
Korea’s Memebox gets extended Series C round
South Korean beauty products e-commerce company Memebox has raised another $60 million in an extended Series C round of funding.
Deal focus: Investing in Australia’s winds of change
Partners Group moves early in response to regulatory easing in Australia's renewables space with $186 million wind power bet
Honda invests in Singapore's VC-backed Grab
Southeast Asia-focused ride-hailing app operator Grab has agreed to a strategic partnership with Honda that will include an investment from the car maker.
Three GPs chosen to manage Australia biomedical fund
OneVentures, Brandon Capital and BioScience Managers have been selected to manage the Australian government’s A$500 million ($375 million) Biomedical Translation Fund (BTF).
Samara to invest $25m in India's SMT
Samara Capital has agreed to invest up to $25 million for a significant stake in Indian medical device manufacturer Sahajanand Medical Technologies (SMT).
Mandarin acquires Italian pharmaceuticals maker
Europe-Asia cross-border focused PE firm Mandarin Capital Partners has committed EUR16.4 million ($17.7 million) for a majority stake in Italian pharmaceutical manufacturer Mipharm.
Anchor-led group invests $107m in Korean mobile content platform
A consortium led by Anchor Equity Partners has committed KRW125 billion ($107 million) to Podotree, the mobile content platform of Korean internet giant Kakao.
GIC to invest $261m in Indonesian cinema operator
GIC, Singapore’s sovereign wealth fund, has committed to invest up to IDR3.5 trillion ($261 million) in Indonesian cinema operator Nusantara Sejahtera Raya (NSR).
India's Amicus reaches $90m first close on debut fund
Amicus Capital Partners, an India-focused PE firm founded last year by former executives from the Carlyle Group and India Value Fund Advisors (IVFA), has reached a first close of $90 million on its debut fund.
China's Innovent Biologics gets $260m Series D round
A fund controlled by China’s State Development & Investment Corporation (SDIC) has led a $260 million Series D round of funding for Innovent Biologics, a domestic biopharmaceutical company working on treatments for cancer, autoimmune disorders and heart...
Asia Climate Partners backs US-based Fluidic Energy
Asia Climate Partners, a fund set up by the Asian Development Bank (ADB), Orix Corp, and Robeco Institutional Asset Management, has committed $20 million to US-based energy storage technology developer Fluidic Energy.
Piramal invests $73m in India's Acme
India’s Piramal Enterprises has invested INR5 billion ($73 million) in Indian renewable energy and telecom solutions company Acme Cleantech Solutions.
KKR, Sino-Ocean invest in Beijing Capital Juda
KKR has partnered with Chinese property developer Sino-Ocean Group Holding to invest HK$1.5 billion ($190 million) in retail outlet developer and operator Beijing Capital Juda.
China’s ORI Healthcare Fund leads $100m round for UK biotech firm
ORI Healthcare Fund, a Chinese sector-focused fund launched by former investment banker at Goldman Sachs, has led a $100 million Series C round for Kymab Group, a UK bio-pharmaceutical company focused on antibody drug discovery.
Sequoia, Mayfield in $19m Series C for India's Knowlarity
Sequoia Capital India and Mayfield have participated in a INR1.3 billion ($19.3 million) Series C round for Indian cloud telephony solutions provider Knowlarity Communications.
Deal focus: Mitsui makes medical inroads
Having lost out to KKR when bidding for Panasonic Healthcare two years ago, Mitsui & Co. seized upon a second chance to get involved and offer the company access to its global network of medical assets
Fund focus: Falcon House shows its staying power
Falcon House Capital comfortably beat the target for its second Indonesia-focused fund, raising $400 million for deployment in middle-market consumer sector businesses
Deal focus: Eight Roads bets on IFMR as a credit hub
Eight Roads sees IFMR Capital as the backbone India's financial services sector needs in order to support growing but still vulnerable non-banking financial companies
Asia PE and upstream energy: Under the pump
Although a low oil price environment has created interesting inroads for PE investors seeking exposure to Asia’s growing energy consumption story, challenges of timing and targeting have slowed uptake
Warburg Pincus, VinaCapital to create SE Asia hotel platform
Warburg Pincus has teamed up with Vietnam-based GP VinaCapital and Don Lam, the firm’s founder, to create a hotel investment platform intended to tap into rising inbound tourism in Southeast Asia, particularly from China.